Skip to main content
. 2018 Jun 13;7(12):e007529. doi: 10.1161/JAHA.117.007529

Table 1.

Baseline Characteristics of Patients With Heart Failure With Preserved Ejection Fraction (n=27 975) According to Serum Sodium Categories

Characteristics Serum Sodium Measurements (mmol/L) P Valuea
115.00–134.99 (N=2928) 135.00–137.99 (N=5239) 138.00–140.99 (N=9272) 141.00–143.99 (N=6192) 144.00–160.00 (N=1809)
Demographics
Sex (% male) 96.3 96.1 96.2 96.0 96.6 0.7922
Black, % 10.3 12.7 13.7 15.0 17.8 <0.0001
Age, y 70.0±11.6 69.9±11.6 70.6±11.5 71.7±11.2 72.5±11.0 <0.0001
BMI (kg/m2)
<18.5, % 11.7 11.2 11.5 11.2 12.3 <0.0001
18.5–24.9, % 22.3 15.2 12.2 12.1 14.2
25–29.9, % 25.1 23.5 23.8 22.5 23.3
30–34.9, % 18.3 21.4 21.7 22.7 21.8
≥35.0, % 22.6 28.7 30.9 31.6 28.5
Clinical
Heart rate, bpm 79.7±15.6 77.7±15.0 75.9±14.8 75.0±14.9 75.8±15.2 <0.0001
Average LVEF, % 60.6±6.1 60.3±5.8 60.2±5.8 60.1±5.7 60.1±5.9 0.0013
Comorbidities
Coronary artery disease, % 42.0 40.5 41.8 41.7 40.7 0.4708
Hypertension, % 86.3 87.2 88.1 89.3 90.1 <0.0001
Hyperlipidemia, % 59.2 65.1 67.1 67.2 63.6 <0.0001
Atrial fibrillation, % 24.1 21.0 22.1 21.7 21.4 0.0286
Chronic obstructive pulmonary disease, % 50.6 47.0 44.2 42.3 41.8 <0.0001
Diabetes mellitus type 2, % 54.0 55.5 53.0 52.2 52.6 0.0065
Anemia, % 42.4 35.8 32.0 31.6 35.2 <0.0001
Laboratory
eGFR (mL/min per 1.73 m2) 67.1±26.8 64.7±25.1 63.9±23.9 61.5±23.6 57.2±23.8 <0.0001
Serum potassium (mmol/L) 4.27±0.59 4.23±0.53 4.20±0.51 4.20±0.51 4.17±0.54 <0.0001
Medications
Calcium channel blocker, % 40.3 38.5 40.4 41.9 42.5 0.0027
ACE/ARB, % 60.9 60.9 61.1 62.2 61.3 0.5696
β‐Blocker, % 60.7 59.7 59.6 59.7 61.0 0.7754

Missing values: race=1378; heart rate=780; eGFR=440; serum postassium=36. ACE‐I/ARB indicates angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker; BMI, body mass index; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction.

a

P value for general association (ANOVA or chi‐square).